Taiwan has ramped up production and imports of the main drug used to treat mycoplasma pneumoniae in children, amid a surge in cases of the respiratory illness reported in China in recent weeks, the Taiwan Food and Drug Administration (TFDA) said Wednesday.
(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)
Latest
- Politics
Taiwan conducts M1A2T tank live-fire drill
07/10/2025 11:59 AM - Politics
U.S. introduces bill to combat China's sabotage of Taiwan's underseas cables
07/10/2025 11:13 AM - Society
Taiwan headline news
07/10/2025 10:38 AM - Business
U.S. dollar up in Taipei trading
07/10/2025 10:29 AM - Society
Rain likely to continue across Taiwan on Thursday
07/10/2025 10:06 AM